Brookfield Asset Management »

Tg Therapeutics shares owned by Brookfield Asset Management

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Brookfield Asset Management from 13F filings

Historical chart of Brookfield Asset Management investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Brookfield Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Brookfield Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $3.1M 123k 24.84
2023-03-31 $7.5M 498k 15.04
2022-12-31 $3.0M 255k 11.83
2022-09-30 $1.8M 298k 5.92
2022-06-30 $980k 231k 4.25
2022-03-31 $1.7M 184k 9.51
2021-12-31 $1.3M 68k 19.00
2021-09-30 $910k 27k 33.30
2021-06-30 $716k 18k 38.81